Abstract:The search for effective methods of cancer treatment and prevention has been a continuous effort since the disease was discovered. Recently, there has been increasing interest in exploring plants and fruits for molecules that may have potential as either adjuvants or as chemopreventive agents against cancer. One of the promising compounds under extensive research is nobiletin (NOB), a polymethoxyflavone (PMF) extracted exclusively from citrus peel. Not only does nobiletin itself exhibit anti-cancer properties, but its derivatives are also promising chemopreventive agents; examples of derivatives with anti-cancer activity include 3′-demethylnobiletin (3′-DMN), 4′-demethylnobiletin (4′-DMN), 3′,4′-didemethylnobiletin (3′,4′-DMN) and 5-demethylnobiletin (5-DMN). In vitro studies have demonstrated differential efficacies and mechanisms of NOB and its derivatives in inhibiting and killing of colon cancer cells. The chemopreventive potential of NOB has also been well demonstrated in several in vivo colon carcinogenesis animal models. NOB and its derivatives target multiple pathways in cancer progression and inhibit several of the hallmark features of colorectal cancer (CRC) pathophysiology, including arresting the cell cycle, inhibiting cell proliferation, inducing apoptosis, preventing tumour formation, reducing inflammatory effects and limiting angiogenesis. However, these substances have low oral bioavailability that limits their clinical utility, hence there have been numerous efforts exploring better drug delivery strategies for NOB and these are part of this review. We also reviewed data related to patents involving NOB to illustrate the extensiveness of each research area and its direction of commercialisation. Furthermore, this review also provides suggested directions for future research to advance NOB as the next promising candidate in CRC chemoprevention.

Chemistry and bioactivity of nobiletin and its metabolites

Nobiletin a Biologically Active Phytoconstituent: Systematic Review

The Multifunctional Effects of Nobiletin and Its Metabolites In Vivo and In Vitro

Identification of Novel Bioactive Metabolites of 5-Demethylnobiletin in Mice

Identification of nobiletin metabolites in mouse urine

Nobiletin as a chemopreventive natural product against cancer, a comprehensive review

[Pharmacological Activities of Myricetin and Its Glycosides].

Biotransformation of Citrus Polymethoxyflavones in Rats and Mice (1044.22)

Nobiletin: a citrus flavonoid displaying potent physiological activity

In vitro human intestinal microbiota biotransformation of nobiletin using liquid chromatography–mass spectrometry analysis and background subtraction strategy

Chemopreventive Effects of Nobiletin and Its Colonic Metabolites on Colon Carcinogenesis

Anti-inflammatory property of the urinary metabolites of nobiletin in mouse

New Insights into Health-Promoting Effects of Nobiletin from Citrus Fruits

Biological activities, Molecular mechanisms, and Clinical application of Naringin in Metabolic syndrome

Practical Synthesis of Polymethylated Flavones: Nobiletin and Its Desmethyl Derivatives

Nobiletin and Derivatives: Functional Compounds from Citrus Fruit Peel for Colon Cancer Chemoprevention

A Recent Review of Citrus Flavanone Naringenin on Metabolic Diseases and Its Potential Sources for High Yield-Production

Chemical Structures, Bioactivities and Molecular Mechanisms of Citrus Polymethoxyflavones

Nobiletin: efficient and large quantity isolation from orange peel extract

Inhibitory effects of nobiletin and its major metabolites on lung tumorigenesis.

Comparative effects of five polymethoxyflavones purified from Citrus tangerina on inflammation and cancer